Skip to main content
Journal cover image

Correction to: miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy.

Publication ,  Journal Article
Huang, Q; Xi, J; Wang, L; Wang, X; Ma, X; Deng, Q; Lu, Y; Kumar, M; Zhou, Z; Li, L; Zeng, Z; Young, KH; Yi, Q; Zhang, M; Li, Y
Published in: J Hematol Oncol
July 3, 2018

The original article [1] contains a spelling error in the authorship; the authors would like to note the correct spelling of the second author, Jiajia Xi.

Duke Scholars

Published In

J Hematol Oncol

DOI

EISSN

1756-8722

Publication Date

July 3, 2018

Volume

11

Issue

1

Start / End Page

90

Location

England

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3201 Cardiovascular medicine and haematology
  • 1112 Oncology and Carcinogenesis
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Huang, Q., Xi, J., Wang, L., Wang, X., Ma, X., Deng, Q., … Li, Y. (2018). Correction to: miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy. J Hematol Oncol, 11(1), 90. https://doi.org/10.1186/s13045-018-0633-1
Huang, Qian, Jiajia Xi, Lei Wang, Xu Wang, Xiaodong Ma, Qipan Deng, Yong Lu, et al. “Correction to: miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy.J Hematol Oncol 11, no. 1 (July 3, 2018): 90. https://doi.org/10.1186/s13045-018-0633-1.
Huang Q, Xi J, Wang L, Wang X, Ma X, Deng Q, et al. Correction to: miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy. J Hematol Oncol. 2018 Jul 3;11(1):90.
Huang, Qian, et al. “Correction to: miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy.J Hematol Oncol, vol. 11, no. 1, July 2018, p. 90. Pubmed, doi:10.1186/s13045-018-0633-1.
Huang Q, Xi J, Wang L, Wang X, Ma X, Deng Q, Lu Y, Kumar M, Zhou Z, Li L, Zeng Z, Young KH, Yi Q, Zhang M, Li Y. Correction to: miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy. J Hematol Oncol. 2018 Jul 3;11(1):90.
Journal cover image

Published In

J Hematol Oncol

DOI

EISSN

1756-8722

Publication Date

July 3, 2018

Volume

11

Issue

1

Start / End Page

90

Location

England

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3201 Cardiovascular medicine and haematology
  • 1112 Oncology and Carcinogenesis
  • 1102 Cardiorespiratory Medicine and Haematology